Curaleaf Holdings Files 6-K with July Press Release

Ticker: CURLF · Form: 6-K · Filed: 2024-07-09T00:00:00.000Z

Sentiment: neutral

Topics: reporting, press-release

Related Tickers: CURA

TL;DR

Curaleaf (CURA) filed a 6-K on 7/9, including a 7/3 press release. Legal Officer Peter Clateman signed off.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on July 9, 2024, reporting for the month of July 2024. The filing includes a press release dated July 3, 2024, as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc. on July 8, 2024.

Why It Matters

This filing indicates ongoing reporting and communication from Curaleaf Holdings, Inc. to the SEC, potentially including important business updates via the attached press release.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily serves as a reporting mechanism and includes a press release, with no immediate financial or operational disclosures that suggest high risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information that Curaleaf Holdings, Inc. has made or is required to make public in Canada or the United States, and has filed or made public elsewhere, for the month of July 2024, including an attached press release.

What is included as an exhibit in this filing?

Exhibit 99.1, a Press Release dated July 3, 2024, is included as an exhibit in this filing.

Who signed the report on behalf of Curaleaf Holdings, Inc. and what is their title?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

On what date was this Form 6-K report signed?

The report was signed on July 8, 2024.

What is Curaleaf Holdings, Inc.'s principal executive office address?

Curaleaf Holdings, Inc.'s principal executive offices are located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Canada.

From the Filing

0001104659-24-078358.txt : 20240709 0001104659-24-078358.hdr.sgml : 20240709 20240708173145 ACCESSION NUMBER: 0001104659-24-078358 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240708 FILED AS OF DATE: 20240709 DATE AS OF CHANGE: 20240708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241105885 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 tm2418992d1_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Canada (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ¨ Form 40-F x SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: July 8, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX 99.1 Press Release dated July 3, 2024 EX-99.1 2 tm2418992d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Curaleaf to Report Second Quarter 2024 Financial and Operational Results STAMFORD, July 3, 2024 -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company") , a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second quarter ended June 30, 2024 after market close on August 7, 2024. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights. Event: Curaleaf Second Quarter 2024 Financial Earnings Conference Call Date: Wednesday, August 7, 2024 Time: 5:00 p.m. ET Live Call: +1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International) Passcode: 4240395 Webcast: https://ir.curaleaf.com/events For interested individuals unable to join the conference call, a dial-in replay of the call will be available until August 14, 2024, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 9598185 About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-

View on Read The Filing